To include your compound in the COVID-19 Resource Center, submit it here.

I-Mab, Bio-Cancer partner to advance biotherapeies

I-Mab Biopharma (Shanghai, China) and Bio-Cancer Treatment International Ltd.

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE